LBA84 Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomised, phase II trial: ENZA-p (ANZUP 1901)

Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Anthony M. Joshua, Andrew Weickhardt, S.T. Lee, Siobhan Ng, Roslyn J. Francis, Jeffrey C. Goh, David A. Pattison, Hendrick Tan, Ian Kirkwood, Shahneen Sandhu, Amy Nguyen, Craig Gedye, Natalie Rutherford, Michael S. Hofman, Andrew Martin, Martin R. Stockler, Ian D. Davis